#KP2

2025-04-30

Kore Potash DRC ( #KP2 ) has released " Quarterly Activities and Cashflow Report " on Wed 30 Apr at 16:11 AEST #today #tax #government #China #Mining
grafa.com/asset/kore-potash-lt

2025-04-02

Heute spontan Auffrischung / #Impfung gegen Covid19 geholt. #KP2 💉💜 Glück gehabt, weil diese Apotheke die "Saison" für Covid und Grippe heute beendet. Weiter geht es erst wieder ab Herbst. Gut fand ich, dass er zumindest auch Maske trug, als er meine sah. #CovidIsNotOver

2025-03-25

Kore Potash DRC ( #KP2 ) has released " Extension of Cleansing Prospectus Offer Period " on Tue 25 Mar at 18:06 AEST #trading #ASIC #ASX #price #Finance
grafa.com/asset/kore-potash-lt

2024-11-24

Gibt es eigentlich Studien darĂĽber,

a) welche Wirkung es genauer hat, wenn man 7, 8, 9 … Mal geimpft ist;

b) welche Wirkung eine Impfung auf den Verlauf hat, wenn man sich zufällig kurz darauf infiziert?

Beide Fragen scheinen eher unbeachtet.

#CovidIsNotOver #ImpfenSchĂĽtzt #Kontrollgruppe #Corona #jn1 #kp2

Giuseppe MichieliGMIK69@mstdn.science
2024-11-11

#Neutralization of #SARS-CoV-2 #KP1, #KP11, #KP2 and #KP3 by #human and murine #sera

Source: npj Vaccines, AbstractWe report SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 neutralizing antibody titers. They displayed increased immune evasion compared to JN.1, especially KP.1 and KP.3, for participants who experienced BF.7/BA.5.2 breakthrough infection or received bivalent (delta/BA.5) vaccine boosting. Second XBB sub-variants breakthrough infection enhanced the neutralization…

etidioh.wordpress.com/2024/11/

Giuseppe MichieliGMIK69@mstdn.science
2024-11-07

#Immunologic and Biophysical #Features of the #BNT162b2 #JN1 – and #KP2-Adapted #COVID19 #Vaccines

Source: BioRxIV, AbstractVaccines remain a vital public health tool to reduce the burden of COVID-19. COVID-19 vaccines that are more closely matched to circulating SARS-CoV-2 lineages elicit more potent and relevant immune responses that translate to improved real-world vaccine effectiveness. The rise in prevalence of the Omicron JN.1 lineage, and subsequent derivative…

etidioh.wordpress.com/2024/11/

Fred_S_at (main)Fred_S_at@mstdn.social
2024-10-15

Neuer Impfstoff #Comirnaty KP.2 trifft in Ă–sterreich ein
orf.at/stories/3372835/
#KP2 #SARSCOV2 #Impfung

Senator Paula Simons🇨🇦Paulatics@mstdn.ca
2024-09-17

Good news - Health Canada has just announced its approval of the new Moderna Covid vaccine, which targets the KP.2 variant. covid-vaccine.canada.ca/ #Covid19 #Covid #vaccine #Canada #HealthCanada #kp2 #Spikevax

Giuseppe MichieliGMIK69@mstdn.science
2024-09-05

Structural and molecular #basis of the #epistasis effect in enhanced affinity between #SARS-CoV-2 #KP3 and #ACE2 biorxiv.org/cgi/content/short/

KP.3, featuring F456L and Q493E, exhibits a markedly enhanced ACE2 binding affinity compared to #KP2 and #JN1 #variant due to synergistic effects between these mutations.

Chuck Darwincdarwin@c.im
2024-08-22

Today, the U.S. Food and Drug Administration approved and granted emergency use authorization ( #EUA ) for
❇️ updated #mRNA #COVID19 #vaccines (2024-2025 formula)
to include a monovalent (single) component that corresponds to the Omicron variant #KP2 strain of SARS-CoV-2.
The mRNA COVID-19 vaccines have been updated with this formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID-19,
including hospitalization and death.

Today’s actions relate to updated mRNA COVID-19 vaccines manufactured by #ModernaTX Inc. and #Pfizer Inc.
In early June, the FDA advised manufacturers of licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 formula) should be monovalent JN.1 vaccines.
Based on the further evolution of SARS-CoV-2 and a rise in cases of COVID-19, the agency subsequently determined and advised manufacturers that the preferred JN.1-lineage for the COVID-19 vaccines (2024-2025 formula) is the KP.2 strain, if feasible.
fda.gov/news-events/press-anno

Chuck Darwincdarwin@c.im
2024-08-21

New #covid #vaccines for summer variants slated for approval late next week

The arrival of updated #Pfizer-BioNTech and new #Moderna vaccines for the #KP2 variant comes well into a summer wave when
đź’ĄAmericans have struggled to find an existing shot.đź’Ą

Consumers should be able to start getting shots at pharmacies within a week after approval
-- and at doctor’s offices soon after.

FDA spokespeople said the agency is prohibited from disclosing the timing of a regulatory action.

The Centers for Disease Control and Prevention recommends updated shots for everyone 6 months and older.

washingtonpost.com/health/2024

Giuseppe MichieliGMIK69@mstdn.science
2024-08-17

[Correspondence] Virological #characteristics of the #SARS-CoV-2 #KP311 #variant thelancet.com/journals/laninf/

SARS-CoV-2 #JN1 variant (#BA28611), arising from BA.2.86.1 with spike protein (S) substitution S:L455S, outcompeted previously predominant #XBB lineages by beginning of 2024. Subsequently, JN.1 subvariants including #KP2 (JN.1.11.1.2) & #KP3 (JN.1.11.1.3), which acquired additional S substitutions (eg, S:R346T, S:F456L, and S:Q493E) have emerged concurrently (appendix pp 19–20).2

Client Info

Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst